Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 56 min ago
Peer-reviewedCC BYOrganic letters

Iron-Catalyzed Defluorinative Alkylation for Accessing Cyclic Acetal-gem-Difluoroalkenes.

  1. 1State Key Laboratory of Synthetic Chemistry and Department of Chemistry, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, China.

Abstract

Cyclic acetals and gem-difluoroalkenes are proven structural motifs in medicinal chemistry, yet their modular incorporation into a densely functionalized hybrid architecture remains an uncharted frontier. Herein, we disclose an Fe-catalyzed reductive defluorinative cross-coupling between trifluoromethyl alkenes and 1,3-dioxolanyl- or 1,3-dioxepanyl-substituted alkyl iodides, enabling the rapid assembly of five- or seven-membered cyclic acetal-embodied fluorinated scaffolds, respectively. This protocol enriches defluorinative coupling versatility and offers streamlined access to structurally diverse pharmaceutically relevant scaffolds.

Related

  1. Biomarker-Targeted O6-Guanine Alkylation Potentiates ATR Inhibitor Response in De Novo and Relapsed/Refractory AML
    P. Bhardwaj, A. Baassiri, R. K. Sundaram +9
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  2. Building recovery capital: co-creating an assets-based community engagement toolkit for people accessing drug and alcohol treatment services
    Amy Beardmore, Devon De Silva, Leila Powell
    Frontiers in public healthPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
  3. Who is not benefitting from contemporary antiretroviral therapy? Correlates of virological non suppression among people with HIV accessing care in a Boston community health center
    Abigail W. Batchelder, Jacklyn Foley, Surabhi Iyer +2
    BMC Public HealthPeer-reviewedCC BY-NC-ND 4.0Infectious diseaseCrossref
  4. Accessing invasion-competent Plasmodium vivax merozoites reveals antibody-dependent NK cell activation
    Jeremy Salvador, Lucas Guselli, Romminea Yeat +12
    Science AdvancesPeer-reviewedCC BY-NCFull textEpidemiology & public healthCrossrefEurope PMC
  5. Recorrido y barreras en el acceso a diagnóstico y tratamiento de la enfermedad de Chagas en Argentina: un mapa desde la experiencia de las personas The journey and barriers to accessing diagnosis and treatment for Chagas disease in Argentina: a patient journey map based on people’s experiences Percurso e barreiras no acesso ao diagnóstico e ao tratamento da doença de Chagas na Argentina: um panorama a partir de experiências pessoais
    Serena Eloisa Moyano, Catalina Canosa, Milagros Girart +2
    Cadernos de saude publicaPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMCEurope PMC
BibTeX
@article{wang2026ironcatalyzed,
  title = {{Iron-Catalyzed Defluorinative Alkylation for Accessing Cyclic Acetal-gem-Difluoroalkenes.}},
  author = {Xiao-Tong Wang and Pui Ying Choy and Chi Wai Cheung and Fuk Yee Kwong},
  journal = {Organic letters},
  year = {2026},
  month = oct,
  doi = {10.1021/acs.orglett.6c03239},
  url = {https://europepmc.org/article/MED/42917824},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Iron-Catalyzed Defluorinative Alkylation for Accessing Cyclic Acetal-gem-Difluoroalkenes.
AU  - Xiao-Tong Wang
AU  - Pui Ying Choy
AU  - Chi Wai Cheung
AU  - Fuk Yee Kwong
PY  - 2026
DA  - 2026/10/01
JO  - Organic letters
DO  - 10.1021/acs.orglett.6c03239
UR  - https://europepmc.org/article/MED/42917824
AB  - Cyclic acetals and gem-difluoroalkenes are proven structural motifs in medicinal chemistry, yet their modular incorporation into a densely functionalized hybrid architecture remains an uncharted frontier. Herein, we disclose an Fe-catalyzed reductive defluorinative cross-coupling between trifluoromethyl alkenes and 1,3-dioxolanyl- or 1,3-dioxepanyl-substituted alkyl iodides, enabling the rapid assembly of five- or seven-membered cyclic acetal-embodied fluorinated scaffolds, respectively. This protocol enriches defluorinative coupling versatility and offers streamlined access to structurally diverse pharmaceutically relevant scaffolds.
SN  - 1523-7060
SN  - 1523-7052
ER  -